{{Drugbox
| IUPAC_name = (''R'')-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]-4-piperidyl]methanol
| image = MDL-100,907_structure.png
| width = 250

<!--Clinical data-->
| tradename =  
| pregnancy_category =  
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number = 139290-65-6
| ATC_prefix = None
| ATC_suffix =  
| PubChem = 5311271
| IUPHAR_ligand = 185
| ChemSpiderID = 4470782
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = EW71EE171J
| ChEMBL = 74355

<!--Chemical data-->
| C=22 | H=28 | F=1 | N=1 | O=3 
| molecular_weight = 373.46 g/mol
| smiles = c3cc(F)ccc3CCN(CC2)CCC2C(O)c(c1OC)cccc1OC
| synonyms = MDL-100,907
}}

'''Volinanserin''' ([[International Nonproprietary Name|INN]]) (developmental code name '''MDL-100,907''') is a highly [[binding selectivity|selective]] [[5-HT2A|5-HT<sub>2A</sub>]] [[receptor (biochemistry)|receptor]] [[receptor antagonist|antagonist]] that is frequently used in [[scientific research]] to investigate the function of the 5-HT<sub>2A</sub> receptor.<ref name="pmid1362159">{{cite journal |vauthors=Schmidt CJ, Fadayel GM, Sullivan CK, Taylor VL |title=5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine |journal=European Journal of Pharmacology |volume=223 |issue=1 |pages=65–74 |date=November 1992 |pmid=1362159 |doi= 10.1016/0014-2999(92)90819-P|url=}}</ref><ref name="pmid19329329">{{cite journal |vauthors=Herth MM, Kramer V, Piel M, Palner M, Riss PJ, Knudsen GM, Rösch F |title=Synthesis and in vitro affinities of various MDL 100907 derivatives as potential 18F-radioligands for 5-HT2A receptor imaging with PET |journal=Bioorganic & Medicinal Chemistry |volume=17 |issue=8 |pages=2989–3002 |date=April 2009 |pmid=19329329 |doi=10.1016/j.bmc.2009.03.021 |url=}}</ref><ref name="pmid19331461">{{cite journal |vauthors=Nic Dhonnchadha BA, Fox RG, Stutz SJ, Rice KC, Cunningham KA |title=Blockade of the serotonin 5-HT2A receptor suppresses cue-evoked reinstatement of cocaine-seeking behavior in a rat self-administration model |journal=Behavioral Neuroscience |volume=123 |issue=2 |pages=382–96 |date=April 2009 |pmid=19331461 |doi=10.1037/a0014592 |url=}}</ref> It was also tested in [[clinical trial]]s as a potential [[antipsychotic]],<ref name="pmid10434243">{{cite journal |vauthors=Offord SJ, Wong DF, Nyberg S |title=The role of positron emission tomography in the drug development of M100907, a putative antipsychotic with a novel mechanism of action |journal=Journal of Clinical Pharmacology |volume=Suppl |issue= |pages=17S–24S |date=August 1999 |pmid=10434243 |doi= |url=}}</ref><ref name="nmi">{{cite book |title=Neurobiology of Mental Illness |author=Dennis S. Charney |author2=Eric J. Nestler |author3=Pamela Sklar|author4=Joseph D. Buxbaum |date=July 2013 |publisher=OUP USA| page=767 |isbn=9780199934959}}</ref> [[antidepressant]],<ref name="pmid15886717">{{cite journal |vauthors=Marek GJ, Martin-Ruiz R, Abo A, Artigas F |title=The selective 5-HT2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine |journal=Neuropsychopharmacology |volume=30 |issue=12 |pages=2205–15 |date=December 2005 |pmid=15886717 |doi=10.1038/sj.npp.1300762 |url=}}</ref> and treatment for [[insomnia]] but was never marketed.<ref name="pmid18673166">{{cite journal |vauthors=Teegarden BR, Al Shamma H, Xiong Y |title=5-HT(2A) inverse-agonists for the treatment of insomnia |journal=Current Topics in Medicinal Chemistry |volume=8 |issue=11 |pages=969–76 |year=2008 |pmid=18673166 |doi= 10.2174/156802608784936700|url=}}</ref>

==See also==
* [[Eplivanserin]]
* [[Glemanserin]]
* [[Ketanserin]]
* [[Pimavanserin]]
* [[Ritanserin]]

==References==
{{Reflist|2}}

{{Antidepressants}}
{{Antipsychotics}}
{{Hypnotics}}
{{Serotonergics}}

[[Category:5-HT2A antagonists]]
[[Category:Fluoroarenes]]
[[Category:Piperidines]]
[[Category:Alcohols]]
[[Category:Phenol ethers]]
[[Category:Abandoned drugs]]


{{nervous-system-drug-stub}}